🔗 Visit the ClinicalTrials.gov page for NCT00545948
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Retracted Genomic signatures to guide the use of chemotherapeutics. | Nat Med | 2006 | 7.45 |
| 2 | Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. | N Engl J Med | 2006 | 6.69 |
| 3 | Tumor acquisition for biomarker research in lung cancer. | Cancer Invest | 2014 | 0.75 |
| 4 | Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed. | Pharmgenomics Pers Med | 2009 | 0.75 |